Phototherapy with narrow-band UVB (NB-UVB), with a peak exclusively at 311 nm wavelength, has been found to be more effective in treating a variety of skin diseases than conventional broad-band UVB (BB-UVB). To assess the difference in carcinogenic activity between NB-UVB and BB-UVB, we investigated skin tumor formation by irradiating albino hairless, Ogg1 knockout mice and C57BL/6J wild counterparts with these two UV sources. We found that the ratio of malignant skin tumors induced by NB-UVB was significantly higher than that induced by BB-UVB. There was no significant difference in carcinogenicity of skin tumor induced by NB-UVB between Ogg1 knockout and wild-type mice. To investigate the possible cause of different carcinogenic activity by the different UV sources, we examined three types of DNA damage: cyclobutane pyrimidine dimer (CPD), (6-4) photoproduct, and 8-oxoguanine (8-oxoG) induced by each UV source. We found that CPD formation following a minimum erythema dose (MED) by NB-UVB was significantly higher than that following 1 MED by BB-UVB, whereas the formation of (6-4) photoproducts and 8-oxoG following BB-UVB was significantly higher than those following NB-UVB exposure. These results suggest that CPD formation is closely related to the higher carcinogenic characteristics of NB-UVB.
INTRODUCTION
Phototherapy, particularly UVB treatment, is widely used to effectively treat various skin diseases. Narrow-band UVB (NB-UVB) treatment, with a peak wavelength of 311 nm, has been shown to be effective for a variety of skin diseases such as psoriasis vulgaris, vitiligo vulgaris, and atopic dermatitis. Some reports indicate that NB-UVB is more therapeutic than broad-band UVB (BB-UVB), which has a wavelength range between 280 and 320 nm (van Weelden et al., 1988; Coven et al., 1997; Walters et al., 1999; Gathers et al., 2002; Samson Yashar et al., 2003) (Figure 1a) . However, the effectiveness of NB-UVB needs to be considered along with its adverse effects, mainly skin carcinogenesis, since UVB causes the development of skin cancers in humans and in other animals (Kraemer, 1997) . There are several reports about skin carcinogenesis following NB-UVB therapy compared with BB-UVB, showing that NB-UVB is more carcinogenic than BB-UVB (van Weelden et al., 1988; Flindt-Hansen et al., 1991; Wulf et al., 1994; Gibbs et al., 1995) , which is now considered to be tentative consensus (Young, 1995; el-Ghorr and Norval, 1997) . In this study, we performed a comparative study of skin tumor formation following exposure to NB-UVB or BB-UVB, using different strains of mice. We also investigated the specific mechanism involved in skin carcinogenesis caused by NB-UVB or BB-UVB, particularly focusing on the types of UV-induced DNA damage such as cyclobutane pyrimidine dimer (CPD), (6-4) photoproduct, and oxidative DNA damage.
Reactive oxygen species, which are generated endogenously by cellular oxygen metabolism or exogenously by UV, environmental mutagens, produce various types of DNA damage (Hattori-Nakakuki et al., 1994; Aburatani et al., 1997) . Among many oxidative DNA base modifications, 8-oxoguanine (8-oxoG) can pair with adenine as well as cytosine during DNA replication, which results in GC-TA transversion mutations (Kasai et al., 1991; Maki and Sekiguchi, 1992) . 8-OxoG is one type of oxidative DNA damage that can result in stable mutations. In mammalian cells, the Ogg1 gene encodes 8-oxoG-DNA glycosylase, a repair enzyme, which removes the oxidized base from DNA. As we have reported, 8-oxoG formation plays an important role in the development of skin cancers following BB-UVB exposure (Kunisada et al., 2005) . In this study, we also studied whether oxidative DNA damage involves in the carcinogenesis by NB-UVB using Ogg1 knockout mice. Overall, we found that NB-UVB induces more malignant skin tumors through the formation of CPD rather than (6-4) photoproduct or 8-oxoG. This finding provides early evidence of the types of DNA damage closely related to UV carcinogenesis caused by NB-UVB or BB-UVB, which have different photocarcinogenic features.
RESULTS
Comparative study: difference of skin carcinogenicity between NB-UVB and BB-UVB We compared the formation of skin tumors following chronic exposure to NB-UVB or BB-UVB (Figure 1a ) using albino hairless, hairy C57BL/6J, and Ogg1 knockout mice (C57BL background), with minimum erythema dose (MED) doses of each type of UVB. MED in albino mice induced by BB-UVB and NB-UVB was 170 and 370 mJ/cm 2 , respectively ( Figure  1b) . MED in C57BL/6J induced by BB-UVB and NB-UVB was 250 and 850 mJ/cm 2 , respectively. We performed histological analyses of all skin tumors that developed. The total numbers of skin tumors induced by NB-UVB are not significantly different from that by BB-UVB (albino hairless mice: P ¼ 0.20; C57BL/6J mice: P ¼ 0.43). However, the ratios of malignant skin tumors produced by NB-UVB were 80.0 and 91.6% in hairless mice and in C57BL/6J mice, respectively. That is a significantly higher rate than that produced by BB-UVB, in which 61.2 and 50.0% were malignant tumors in hairless mice and in C57BL/6J mice, respectively (albino hairless mice: P ¼ 0.026; C57BL/6J mice: P ¼ 0.022) (Tables 1 and 2 and Figure 2a and b). Since we previously reported the involvement of oxidative stress in photocarcinogenesis by comparing the BB-UVB induced formation of skin tumors between wild-type and Ogg1 knockout mice (Kunisada et al., 2005) , we then also evaluated the involvement of oxidative DNA damage in the development of skin tumors following chronic NB-UVB exposure. The number of skin tumors and rates of malignant tumors induced by NB-UVB was not significantly different irrespective of Ogg1 genotypes (Table 2 and Figure 2b) .
Immunohistochemistry: accumulation of DNA damages in the epidermis following NB-UVB or BB-UVB We then investigated the relevance of UV-induced DNA damage, such as CPD, (6-4) photoproduct, and 8-oxoG, for Unidentified tumors were those which we were not able to make the diagnosis due to the failure of the embedding the specimens.
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The number of skin tumor-bearing mice at the end of the experiment. The number of skin tumors/total skin tumors histologically. the different ratio of malignant skin tumors following NB-UVB or BB-UVB irradiation. We immunohistochemically quantified the accumulation of those DNA damage in epidermis and dermis following NB-UVB or BB-UVB exposure using Image J analysis software. The strong accumulation of CPD was observed in epidermal cells at both 3 minutes and 3 hours after NB-UVB or BB-UVB exposure at similar levels. The lesser amount of immunofluorescent staining was observed in dermis at 3 minutes and 3 hours after NB-UVB or BB-UVB exposure at similar level. However, a greater amount of immunofluorescent staining was observed in epidermis at 72 hours after NB-UVB exposure than after BB-UVB exposure (Po0.0001) ( Figure  3a ). There was no significant difference in intensity of CPD irrespective of Ogg1 genotype at any time after NB-UVB or BB-UVB exposure (data not shown). Conversely, the staining intensity of (6-4) photoproduct was more significant in both epidermal and dermal cells at 3 minutes (epidermis: Po0.0001; dermis: Po0.001, respectively) and 3 hours (epidermis: Po0.0001; dermis: Po0.05, respectively) after BB-UVB exposure than after NB-UVB exposure. Staining signal was low in both epidermal and dermal cells 72 hours after exposure to either NB-UVB or BB-UVB ( Figure 3b ). There was no significant difference in the intensity of (6-4) photoproduct in epidermal cells irrespective of Ogg1 genotype at any time after either NB-UVB or BB-UVB exposure (data not shown). The accumulation of 8-oxoG was significantly strong for epidermal cells 3 hours after BB-UVB exposure than after NB-UVB exposure in both Ogg1 knockout mice and wild-type mice (Po0.0001) ( Figure 3c ). The lesser amount of immunofluorescent staining was observed in dermis after 3 and 72 hours after NB-UVB or BB-UVB exposure with no significance. There was no significant difference in intensity of 8-oxoG for epidermal cells irrespective of Ogg1 genotype at any time after NB-UVB exposure. However, the intensity of 8-oxoG in the epidermis was much higher in Ogg1 knockout mice than in wild-type mice 72 hours after BB-UVB exposure (Po0.0001) (Figure 3c ), which confirms our previous studies (Kunisada et al., 2005) . Unidentified tumors were those which we were not able to make the diagnosis due to the failure of the embedding the specimens. The number of skin tumor-bearing mice at the end of the experiment. The number of skin tumors/total skin tumors histologically.
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Induction of skin tumors: comparison between NB-UVB and BB-UVB in Ogg1 wild and knockout mice Furthermore, we evaluated the skin tumor induction by chronic NB-UVB or BB-UVB exposure in relevance of oxidative DNA damage caused by Ogg1 gene disruption. As shown in Figure 4 , in wild-type mice, the first appearance of tumor was 3 weeks earlier and the time of 100% incidence was 3 weeks earlier in NB-UVB-irradiated mice than in BB-UVB-irradiated mice. Tumor induction by NB-UVB was not significantly different irrespective of Ogg1 genotype.
DISCUSSION
In this study, we showed that chronic exposure of 1 MED of NB-UVB induces malignant skin tumor in mice at significantly higher frequency than that of BB-UVB (albino hairless mice: P ¼ 0.026; C57BL/6J mice: P ¼ 0.022) (Tables 1 and 2 and Figure 2a and b) . However, there was no significant difference in the number of tumors induced by these two UV sources. To begin this comparative photocarcinogenesis study between NB-UVB and BB-UVB irradiation on mice, we had to determine a MED for each strain of mouse. Setting a MED for NB-UVB or BB-UVB for mice or humans is the most critical parameter, which might lead to different outcomes. There are, however, several reports which have determined the optimal ratios of doses for NB-UVB or BB-UVB to induce erythema Gibbs et al., 1995) . Originally, the ratio of BB/NB-UVB was calculated by weighting the spectral irradiance according to the Commission Internationale de l'Eclairage (CIE) erythema action spectrum for human skin and was 1:4.2 (Diffey et al., 1984) . After that report, Flindt-Hansen et al. reported that the ratio of BB/NB-UVB was 1:10.8 and that NB-UVB was more carcinogenic. The ratio of 1:7.4 and 1:6.3 was also reported for pigmented hairless and albino hairless mice, respectively . Kinetic study of epidermal DNA damages after NB-UVB or BB-UVB. Immunostaining of CPD, (6-4) photoproduct, and 8-oxoG in skin specimens using TDM-2, 64M-1, N45.1, at upper panel of (a-c), respectively, were measured 3 minutes, 3, and 72 hours after NB-UVB or BB-UVB exposure at the dose of 1 MED along with Ogg1 knockout (KO) mice. The boundary between epidermis and dermis is marked with a broken line. Representive photomicrographs of at least three independent experiments are shown. Bar ¼ 100 mm. Relative levels of CPD, (6-4) photoproduct, and 8-oxoG in epidermis and dermis were determined by densitometry in lower panel of (a-c), respectively. *P, **Po0.0001, w Po0.05. Gibbs et al., 1995) . In contrast, there was another report that the ratio was 1:2.8 for humans . Our data on the ratio of BB/NB-UVB that induced a MED was determined in our laboratory, which simulated the clinical situation for humans (Figure 1b) . We obtained a ratio 1:2.2 for albino hairless mice and 1:3.4 for C57BL/6J mice. Our measurement of the BB/NB-UVBinduced MED is similar to a report by Hansen et al., who speculated that wavelengths below 298 nm or more than 328 nm would be overestimated from the CIE erythema action. The ratio of malignant tumor induced by NB-UVB versus that by BB-UVB is higher in C57BL strain (91.6 vs 50.0%) in comparison with that of albino (80.0 vs 61.2%). The reason for this is possibly because the ratio of NB/BB-UVB dose irradiated to C57BL is higher (3.4 times) than that irradiated to albino hairless (2.2 times) if the dose is determined by MED. To elucidate the specific mechanism of the higher carcinogenicity of NB-UVB, we focused on types of DNA damage induced by UVB, such as CPD, (6-4) photoproduct, and 8-oxoG. One reason why we focused on the DNA damage is that there have been reports indicating scale differences in the action spectrum between the induction of CPD and (6-4) photoproduct observed in the UVB spectrum (Mitchell, 1988; Matsunaga et al., 1991; Mizuno et al., 1991) . Another reason is that recently the involvement of reactive oxygen species in carcinogenesis has been suggested (Nishigori et al., 2004; Kunisada et al., 2005) . Although UVB has been shown to induce 8-oxoG, we do not know the action spectrum for 8-oxoG formation. Thus, we consider it is of importance to see whether NB-UVB is highly productive of 8-oxoG or not. We characterized the accumulation of such DNA damage caused by NB-UVB or BB-UVB irradiation using monoclonal antibodies and found that significantly fewer (6-4) photoproduct were produced by NB-UVB, whereas BB-UVB produced both CPD and (6-4) photoproduct (Figure 3a and b) . Moreover, CPD produced by NB-UVB remained even 72 hours after exposure, which implies that CPD induced by NB-UVB are more abundant in epidermal cells, since the repair ability should be the same among the inbred strain. The mice were irradiated with the UVB dose inducing 1 MED both for tumor induction and DNA damage detection, and this dose seems to be too high to accurate quantification of CPD fluorescence intensity at post-24 hours UVB exposure. Thus, time course studies were performed to assess the accumulation of CPD at 3 minutes, 3, and 72 hours after exposure with precision. These suggest that the more efficient induction of malignant skin tumors by NB-UVB can be attributed to CPD formations in epidermal cells rather than to (6-4) photoproduct formation. There are many reports indicating the link between CPD induced by UV exposure and the UV-induced mutations in tumor-related genes such as p53 (Giglia-Mari and Sarasin, 2003) , which explains our results. Our results showed that the ratio of malignant tumor formation is higher in NB-UVB-exposed group although the number of tumors are not different, which might imply the larger amount of CPD is involved not only in the initiation phase (the formation of mutation) but also modulate the immunological response in a way that favors tumor development, since there are several pieces of evidence that CPD play a very important role in UV-induced immune suppression . This is early evidence that shows the higher amount of CPD is formed by NB-UVB, which partly explains the higher incidence of malignant tumors induced by NB-UVB. Our immunofluorescence time course studies also revealed that much higher accumulation of (6-4) photoproduct 3 hours after BB-UVB than that after NB-UVB exposure result from production of larger amounts of (6-4) photoproduct by BB-UVB than NB-UVB, since there are significant differences in the accumulation of (6-4) photoproduct as early as 3 minutes after irradiation.
Recently, the involvement of 8-oxoG has been suggested in photocarcinogenesis (Basset-Seguin et al., 1994; Agar et al., 2004; Nishigori et al., 1994 Nishigori et al., , 2004 . Indeed, we previously found that BB-UVB exposure generates 8-oxoG in epidermal cells and that Ogg1 knockout mice, which are not able to remove the oxidized base from DNA, are more prone to having skin cancers following chronic BB-UVB irradiation, which indicates that oxidative DNA damage caused by BB-UVB exposure, as well as pyrimidine photoproducts, plays an important role in the development of skin cancers (Kunisada et al., 2005) . There was no significant difference in either mean number of tumor nor in ratio of malignant tumor formation induced by continuous NB-UVB exposure between Ogg1 knockout mice and wild-type counterpart (Table 2 and Figure 2b ). Although the onset of developing skin tumor with chronic NB-UVB irradiation in Ogg1 knockout mice appears earlier than that in wild-type mice, the tumor induction lines afterwards are similar irrespective of Ogg1 genotype, which indicates that oxidative DNA damage is rarely responsible for NB-UVB-induced carcinogenesis. As for the amount of 8-oxoG produced by NB-UVB and BB-UVB, there are several controversial reports (Budiyanto et Figure 4 . Difference of tumor induction following NB-UVB or BB-UVB with Ogg1 genotype. Effects of chronic NB-UVB and BB-UVB exposure on the onset and incidence of tumors along with Ogg1 genotype. Mice that died during the experiment were not included. The graphs of BB-UVB were overlaid from the data in our previous work.
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2006). Therefore, we assessed accumulation of 8-oxoG by single NB-UVB exposure using each Ogg1 genotype mice as well. Immunohistochemically no significant difference in intensity of 8-oxoG staining was observed after NB-UVB exposure irrespective of Ogg1 genotype (Figure 3c ), indicating that very little amount of 8-oxoG is produced by NB-UVB. Figure 3c also showed that much less amount of 8-oxoG was formed after 1 MED by NB-UVB in comparison to that by BB-UVB, which is consistent with those reported by Orimo et al. (2006) . As for tumor induction, wild-type mice irradiated with NB-UVB began to develop tumors 3 weeks earlier than with BB-UVB, and 100% incidence was at 41 weeks, 3 weeks earlier than with BB-UVB (Figure 4 ). This shows that NB-UVB also promotes the onset of tumor development earlier than BB-UVB, which is compatible with the report by Flindt-Hansen et al.
In conclusion, we demonstrate that CPD formation in epidermal cells, rather than formation of (6-4) photoproduct or 8-oxoG, is closely related to the carcinogenic activity of NB-UVB. The most important factor to be considered is the balance between the efficiency and carcinogenicity of NB-UVB treatment required for treating several skin diseases (Gibbs et al., 1995; Weischer et al., 2004) . If the tumor incidence is plotted to the total accumulative dose, BB-UVB induces skin tumors by smaller dose (Supplementary data). However, we usually use higher dose in treating with NB-UVB when we decide the initial therapeutic dose being standardized by MED. There are reports that the effectiveness of NB-UVB treatment has an advantage over BB-UVB treatment for psoriasis (Coven et al., 1997 , Walters et al., 1999 . NB-UVB phototherapy has to be considered in the balance between the higher carcinogenic characteristics and the higher therapeutic benefits. Thus, it will be ideal if we will be able to determine the optimum dose and wavelength to obtain the effective immunomodulation without carcinogenicity.
MATERIALS AND METHODS

Mice
Albino hairless albino mice (Balb/cA Kud-hr) were used for the comparative study of NB-UVB and BB-UVB continuous irradiation. C57BL/6J Ogg1 knockout mice (Sakumi et al., 2003) , together with wild-type mice, were used to study skin tumor production following NB-UVB exposure. We inbred Ogg1 heterozygous mice (C57BL/6J, N ¼ 12) and genotype was determined as described previously (Sakumi et al., 2003) . These mice were also used for DNA damage detection by UVB exposure using immunohistochemical study. Mice aged 12-15 weeks were selected and divided into groups of 10 mice each corresponding to each type of UVB source and Ogg1 genotype, in wild-type and Ogg1 knockout mice. The mice were housed under special pathogen-free conditions, and all animal experiments were conducted according to the Guideline for Animal Experimentation at Kobe University School of Medicine.
NB-UVB and BB-UVB irradiation
Banks of six TL 20W/01RS and TL 20W/12RS fluorescent lamps (Philips, Eindhoven, Holland) were used to irradiate the mice with NB-UVB or BB-UVB, respectively. TL 20W/01RS lamps emit in a narrow peak around 311 nm exclusively. TL 20W/12RS lamps emit a continuous spectrum from 275 to 390 nm, with a peak emission at 313 nm; approximately 65% of that radiation is within the UVB wavelength range (Figure 1a) . The irradiance was 7.6 J/m 2 /second for TL 20W/01RS lamps and 3.8 J/m 2 /second for TL 20W/12RS lamps at a distance of 40 cm, as measured by an IL1400A radiometer/ photometer (International Light Inc., Peabody, MA), or an UVR-305/ 365D digital radiometer (Tokyo Kogaku Kikai KK, Tokyo, Japan), respectively. For skin tumor production, the mice were placed 40 cm below the bank of lamps and were irradiated three times per week over 30 weeks (for albino hairless mice) and over 40 weeks (for C57BL/6J mice, after shaving their backs). For the TL 20W/01RS lamps, exposures of 370 or 850 mJ/cm 2 are the approximate subMEDs for albino hairless mice and for C57BL/6J mice, respectively. Exposures with 170 or 250 mJ/cm 2 are the approximate MEDs for albino hairless mice and for C57BL/6J mice, respectively, for the TL 20W/12RS lamp ( Figure 1b ). For immunohistochemical detection of CPD, (6-4) photoproduct and 8-oxoG after UVB irradiation, mice aged 12 weeks were irradiated with the same doses of MED irradiance corresponding to each type of UVB source.
Immunohistochemistry
For detection of CPD or (6-4) photoproduct, skin specimens were obtained at 3 minutes, 3 and 72 hours after NB-UVB or BB-UVB irradiation. For detection of 8-oxoG, skin specimens were taken at 3 and 72 hours after NB-UVB or BB-UVB irradiation. Skin specimens were subjected to immunohistochemical staining as described previously (Kunisada et al., 2005) using primary mouse monoclonal antibodies against CPD (TDM-2), (6-4) photoproduct (64M-1) (Mizuno et al. 1991) , or 8-oxoG (N45.1) (Hattori et al., 1996) . Specimens were observed using an Olympus FluoView confocal laser scanning microscope (Olympus Co. Ltd., Nagano, Japan).
Observation and measurement of cumulative tumor incidence
After the chronic UVB exposure, we observed tumor formation until all mice developed skin tumors. The numbers of tumors with diameters larger than 2 mm in diameter were counted. Tumors less than 2 mm in diameter, or those that regressed, were not counted. The numbers of tumors on mice that died during the experiment were not included. All mice were killed at the final observation and all skin tumors were excised and examined histologically with hematoxylin and eosin staining. In addition, all mice including mice that died during the experiment were subjected to autopsy to confirm whether they had internal spontaneous tumors macroscopically.
Histological analysis
Tumors examined histologically were classified as malignant or benign. Malignant tumors were classified as squamous cell carcinomas (tumors with atypical epithelial differentiation) or sarcomas (tumors with atypical mesenchymal differentiation), whereas benign tumors were classified as papillomas (tumors with papillomatous growth of epidermal cells without atypicality) or cysts.
Statistical analysis
Results are expressed as the mean7SD. Statistical differences were determined using an un-paired t-test for mean number of tumors/
